5MELTZER M I,COX N J,FUKUDA K. The economic impact of pandemic influenza in the United States: priorities for intervention[J]. Emerg Infect Dis, 1999,5(5) :659.
6THOMPSON W W, SHAY D K, WEINTRAUB E, et al. Influenza-assoc, iated hospitalizations in the United States[J]. JAMA,2004,292:1333.
7FARR B M, GWALTNER J M Jr, ADAMS K F, et al. Intranasal interferon-alpha 2 for prevention of natural rhinovirus colds[J]. Antimicrobial Agents and Chemotherapy, 1984,26 (1):31.
8COSTAQLIOLA D, FLAHAULT A, GALINEC D, et al. A routine tool for detection and assessment of epidemics of influenza-like syndromes in France[J]. Am J Public Health, 1991,81(1) :97.
9SZEKELY L, BIKK A, GALFFY G. Prevention of acute respiratory infections in healthy young adults by using oral immunomodulators[J]. Orv Hetil, 1997,138(43) :2743.
10GAO L, YU S, CHEN Q, et al. A randomized controlled trial of low-dose recombinant human interferons alpha - 2b nasal spray to prevent acute viral respiratory infections in military recruits[J]. Vaccine, 2010,28(28): 4445.
